Skip to main content

Neurobiology of Supersensitive D1 and D2-Dopamine Receptors after 6-Hydroxydopamine Lesions

  • Chapter
Pharmacology and Functional Regulation of Dopaminergic Neurons

Abstract

Administration of L-DOPA to rats treated as neonates or as adults with 6-hydroxydopamine (6-OHDA; Breese and Traylor, 1970; Smith et al., 1973) results in enhanced behavioral responses (Breese, 1975). However, behavioral responses to L-DOPA differ depending on the age at which dopaminergic fibers are destroyed (Breese et al., 1984). For example, following L-DOPA, rats lesioned with 6-OHDA as neonates show self-biting and self-mutilation behavior, but rats treated as adults do not (Breese et al., 1984). In initial experiments, Breese et al. (1984) observed that cis flupentixol was more potent than haloperidol in antagonizing self-biting induced by L-DOPA in neonatally lesioned rats, suggesting that D1-dopamine (DA) receptors were involved in the behavioral supersensitivity observed in rats whose DA-containing neurons were destroyed during development (Breese et al., 1984). The availability of agonists and antagonists with specificity for D1-and D2-DA receptors and animal models by which to study D1-and D2-DA receptor responses allowed us to test this hypothesis as well as to evaluate further the neurobiology of these receptor subtypes (Breese et al., 1985ab, 1986, 1987).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Breese, G.R. (1975). Chemical and immunochemical lesions by specific neurotoxic substances and antisera. Handbook of Psychopharmacology, 1, 137–189.

    CAS  Google Scholar 

  • Breese, G.R., Baumeister, A.A., McCown, T.J., Emerick, S.G., Prye, G.D., Crotty, K. and Mueller, R.A. (1984). Behavioral differences between neonatal and adult 6-hydroxydoparainetreated rats to dopamine agonists: Relevance to neurological symptoms in clinical syndromes with reduced brain dopamine. J. Pharmacol. Exp. Ther., 231, 343–354.

    PubMed Central  CAS  PubMed  Google Scholar 

  • Breese, G.R., Baumeister, A., Napier, T.C., Prye, G.D. and Mueller, R. A. (1985a). Evidence that D-1 dopamine receptors contribute to the supersensitive behavioral responses induced by L-dihydroxyphenylalanine in rats treated neonatally with 6-hydroxydopamine. J. Pharmacol. Exp. Ther., 234, 287–295.

    Google Scholar 

  • Breese, G.R., Duncan, G.E., Napier, T.C., Bondy, S.C., Iorio, L.C. and Mueller, R.A. (1987). 6-Hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1 and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding. J. Pharmacol. Exp. Ther., 240, 167–176.

    PubMed Central  CAS  PubMed  Google Scholar 

  • Breese, G.R., Mueller, R.A., Napier, T.C. and Duncan, G.E. (1986). Neurobiology of D1 dopamine receptors after neonatal-6-OHDA treatment: Relevance to Lesch-Nyhan disease. Adv. Exp. Med. Biol., 204, 197–215.

    Article  CAS  PubMed  Google Scholar 

  • Breese, G.R., Napier, T.C. and Mueller, R.A. (1985b). Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: Functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats. J. Pharmacol. Exp. Ther., 234, 447–455.

    CAS  PubMed  Google Scholar 

  • Breese, G.R. and Traylor, T.D. (1970). Effects of 6-hydroxydopamine on brain norepinephrine and dopamine: Evidence for selective degeneration of catecholamine neurons. J. Pharmacol. Exp. Ther., 174, 413–420.

    PubMed Central  CAS  PubMed  Google Scholar 

  • Bruno, J.P., Stricker, E.M. and Zigmond, M.J. (1985); Rats given dopamine-depleting brain lesions as neonates are subsensitive to dopaminergic antagonists as adults. Behav. Neurosci. 99, 771–775.

    Article  CAS  PubMed  Google Scholar 

  • Creese, I., Burt, D.R. and Snyder, S.H. (1977). Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity. Science 197, 596–598.

    Article  CAS  PubMed  Google Scholar 

  • Creese, I. and Chen, A. (1985). Selective D1 dopamine receptor increase following chronic treatment with SCH-23390. Eur. J. Pharmacol. 109, 127–128.

    Article  CAS  PubMed  Google Scholar 

  • Criswell, H.E., Mueller, R.A. and Breese. G.R. (1987). Sensitization following repeated administration of the direct acting D1-dopamine agonist SKF-38393 in neonatally but not adult-6-OHDA lesioned rats. Soc. Neurosci. Abst.

    Google Scholar 

  • Duncan, G., Criswell, H., McCown, T.J., Paul, I., Mueller, R.A. and Breese, G.R. (1987). Behavioral and neurochemical responses to haloperidol and SCH-23390 in rats treated neonatally or as adults with 6-hydroxydopamine. J. Pharmacol. Exp. Ther. In Press.

    Google Scholar 

  • Iorio, L.C., Barnett, A., Billard, W. and Gold, E.H. (1986). Benzazepines: Structure-activity relationships between D1 receptor blockade and selected pharmacological effects. Adv. Exp. Med. Biol. 204, 1–14.

    Article  CAS  PubMed  Google Scholar 

  • Lloyd, K.G., Hornykiewicz, O., Davidson, L., Shannak, K., Farley, I., Goldstein, M., Shibuya, M., Kelley, W.N. and Fox, I.H. (1981). Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome. N. Eng. J. Med., 305, 1106–1111.

    Article  CAS  Google Scholar 

  • MacKenzie, R.G. and Zigmond, M.J. (1985). Chronic neuroleptic treatment increases D2 but not D1 receptors in rat striatum. Eur. J. Pharmacol. 113, 159–165.

    Article  CAS  PubMed  Google Scholar 

  • Smith, R.D., Cooper, B.R. and Breese, G.R. (1973). Growth and behavioral changes in developing rats treated intraci8ternally with 6-hydroxydopamine: Evidence for involvement of brain dopamine. J. Pharmacol. Exp. Ther., 185, 609–619.

    CAS  PubMed  Google Scholar 

  • Walters, J.R., Bergstrom, D.A., Carlson, J.H., Chase, T.N., and Braun, A.R. (1987). D1 dopamine receptor activation required for postsynaptic expression of D2 agonist effects. Science 236, 719–722.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Copyright information

© 1988 George R. Breese, Hugh E. Criswell, Gary E. Duncan, Thomas J. McCown and Robert A. Mueller

About this chapter

Cite this chapter

Breese, G.R., Criswell, H.E., Duncan, G.E., McCown, T.J., Mueller, R.A. (1988). Neurobiology of Supersensitive D1 and D2-Dopamine Receptors after 6-Hydroxydopamine Lesions. In: Beart, P.M., Woodruff, G.N., Jackson, D.M. (eds) Pharmacology and Functional Regulation of Dopaminergic Neurons. Satellite Symposia of the IUPHAR 10th International Congress of Pharmacology. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-10047-7_19

Download citation

Publish with us

Policies and ethics